MedPath

Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders

Phase 2
Conditions
In Vitro Fertilization
Poor Ovarian Response
Interventions
Drug: Melatonin
Other: Placebo
Registration Number
NCT02993588
Lead Sponsor
Assiut University
Brief Summary

The purpose of this study is to investigate the impact of melatonin administration on in vitro fertilization (IVF/ICSI) outcomes namely the total number and quality of the oocytes and embryos in the prospective poor responders.

Detailed Description

The prospective poor responders have been associated with lower number and poorer oocyte quality. Melatonin is suggested to have antioxidative effects which may contribute to improving the IVF/ICSI outcomes in this group of patients who expected to have poor outcomes. However, the expected beneficial effects of melatonin have not yet been investigated. The purpose of this study is to investigate the impact of melatonin administration on IVF/ICSI outcomes namely the total number and quality of the oocytes and embryos in the prospective poor responders. A randomized, double-blinded, placebo-controlled study is used to investigate the impact of melatonin on the IVF/ICSI outcomes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Prospective poor responder with AMH < 1 ng/ml and AFC < 8 (in both ovaries).
Read More
Exclusion Criteria
  • Severe male factor infertility.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MelatoninMelatoninMelatonin 6 mg tablet once daily.
PlaceboPlaceboPlacebo tablet once daily
Primary Outcome Measures
NameTimeMethod
Total number of retrieved mature oocytesOn the day of oocyte retrieval procedure
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Osama Abdalmageed

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath